logo

For the Inventor, By the Inventor

Basel, Switzerland

Sandoz Ag

Calculating rank
USPTO Granted Patents = 149

% Expired Patents = 52.3



Trademarks = 142

Forward Citations = 321

Loading Chart...
Loading Chart...

235 inventors (with patents filed for the assignee):

goldMedal Johannes Ludescher (19 out of 57 patents)

silverMedal Hubert Sturm (17 out of 32 patents)

bronzeMedal Josef Wieser (13 out of 25 patents)

4.  Ulrich Griesser (12 out of 14 patents)

5.  Franz Xaver Schwarz (11 out of 12 patents)

6.  Andreas Hotter (11 out of 15 patents)

7.  Arthur Pichler (10 out of 12 patents)

8.  Christoph Langes (9 out of 11 patents)

9.  Dominic De Souza (8 out of 9 patents)

10.  Marijan Stefinovic (7 out of 7 patents)

11.  Peter Kremminger (7 out of 24 patents)

12.  Martin Albert (7 out of 7 patents)

13.  Mahendra R Patel (6 out of 31 patents)

14.  Verena Adamer (6 out of 7 patents)

15.  Erwin Schreiner (6 out of 7 patents)


Core Competencies:
Drug Delivery Device
Inhaler
Formulation
Crystalline Forms
Pharmaceutical Composition
Microparticles
Recombinant Protein
Stable Composition
Synthesis
Crystal Forms
Solid Dispersion
Anti-Cancer Agents

149 patents:

1. 12590095 - Crystalline forms of an orally available, selective kit and PDGFR kinase inhibitor (2026-03-31),
2. 12453826 - Inhaler device (2025-10-28),
3. D1088218 - Drug delivery device (2025-08-12),
4. D1087326 - Drug delivery device (2025-08-05),
5. D1083620 - Packaging (2025-07-15),
6. D1067421 - Inhaler (2025-03-18),
7. D1057937 - Drug delivery device (2025-01-14),
8. D1042795 - Drug delivery device (2024-09-17),
9. 12043590 - Co-crystals comprising levothyroxine and a dicarboxylic acid (2024-07-23),
10. D1029237 - Drug delivery device (2024-05-28),
11. 11970450 - Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor (2024-04-30),
12. 11512068 - Process for the preparation of crystalline ridinilazole using acid addition salts (2022-11-29),
13. 11479798 - Recombinant host cell with altered membrane lipid composition (2022-10-25),
14. 11446381 - Stable aqueous formulation for growth hormone (2022-09-20),
15. 11273128 - Elagolix formulation (2022-03-15),
Company Overview
Sandoz AG, headquartered in Basel, Switzerland, is a global leader in the development and manufacturing of drug delivery devices. The company specializes in innovative solutions such as inhalers and advanced pharmaceutical formulations, focusing on enhancing the stability and efficacy of therapeutic compositions. Sandoz is committed to advancing drug delivery technologies, including the use of microparticles and recombinant proteins, to improve patient outcomes and accessibility to essential medications.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

Sandoz Ag USPTO Patent Assignee Logo
149 Patents

#11 in Basel

#124 in Switzerland

#5,483 in the World

Basel, CH
Basel, Switzerland

Sandoz Ag

Forward Citations = 321

235 inventors:

goldMedal Johannes Ludescher (19 out of 57 patents)

silverMedal Hubert Sturm (17 out of 32 patents)

bronzeMedal Josef Wieser (13 out of 25 patents)

4.  Ulrich Griesser (12 out of 14 patents)

5.  Franz Xaver Schwarz (11 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sandoz Ag. Retrieved from https://idiyas.com/company/sandoz-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…